High Flow Nasal Cannula Weaning in Acute Bronchiolitis
ConditionAcute Bronchiolitis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0-12
SponsorKuopio University Hospital
About this trial
The goal of this clinical study is to compared two different strategies to end high flow nasal cannula treatment in acute bronchiolitis. This study compared the immediate ending of high flow treatment to weaning strategy, in which the flow rate is gradually decreased. The aim is to assess if the immediate ending shortens the hospitalization time and whether it is a safe strategy.
Eligibility criteria
Qualifiers
Clinically diagnosed acute bronchiolitis
High flow nasal cannula treatment has lasted for at least 12 hours
Measured saturation 95 or more with room air
High flow rate is maximum 2l/kg/min
Disqualifiers
Major congenital anomaly of lungs, hearts or diaphragm
Bacterial pneumonia
Parents do not give consent
Trial design
Treatments tested in this trial
- High flow nasal cannula immediate ending
- High flow nasal cannula weaning
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Kuopio University Hospital
Lead sponsor
Central Finland Hospital District
Collaborator
Mikkeli Central Hospital
Collaborator
Siun sote
Collaborator
Source ClinicalTrials.gov